Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Berger

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Nature Communications|May 27, 2023
macroH2A2 antagonizes epigenetic programs of stemness in glioblastomaAna Nikolic, Francesca Maule, Anna Bobyn, et al.
Neuroimage|August 31, 2021
Connectome 2.0: Developing the next-generation ultra-high gradient strength human MRI scanner for bridging studies of the micro-, meso- and macro-connectomeSusie Y Huang, Thomas Witzel, Boris Keil, et al.
Nature Communications|July 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsJasmin Bartl, Marco Zanini, Flavia Bernardi, et al.
Immunity|September 3, 2024
Autoantigen-specific CD4<sup>+</sup> T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseasesCarina Saggau, Petra Bacher, Daniela Esser, et al.
The Lancet. Oncology|October 3, 2024
Radiotherapy and theranostics: a Lancet Oncology CommissionMay Abdel-Wahab, Francesco Giammarile, Mauro Carrara, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Nature Communications|May 27, 2023
macroH2A2 antagonizes epigenetic programs of stemness in glioblastomaAna Nikolic, Francesca Maule, Anna Bobyn, et al.
Neuroimage|August 31, 2021
Connectome 2.0: Developing the next-generation ultra-high gradient strength human MRI scanner for bridging studies of the micro-, meso- and macro-connectomeSusie Y Huang, Thomas Witzel, Boris Keil, et al.
Nature Communications|July 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsJasmin Bartl, Marco Zanini, Flavia Bernardi, et al.
Immunity|September 3, 2024
Autoantigen-specific CD4<sup>+</sup> T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseasesCarina Saggau, Petra Bacher, Daniela Esser, et al.
The Lancet. Oncology|October 3, 2024
Radiotherapy and theranostics: a Lancet Oncology CommissionMay Abdel-Wahab, Francesco Giammarile, Mauro Carrara, et al.
Pageof 13